The Bavarian Society for Obstetrics and Gynaecology (BGGF) wants to promote gynaecological and obstetric science and organised a symposium from 12 to 14 September 2019 at Munich's Klinikum Rechts der Isar. And who should not be missing here? Tahovital GmbH with its product tigovit Green Tea Complex, which conducted a study with women affected by fibroids at the Charité Women's Hospital in 2019.
In addition to tigovit, tigovit founder Tanja Hohenester also presented the latest product: tigosol is a premium vitamin D complex with a highly concentrated triple combination of active ingredients. Valuable green tea, the sunshine vitamin D3 and Bacillus subtilis Cultures.
"With its unique composition, tigosol specifically combats deficiency symptoms and ensures that the vitamin D is actually utilised and absorbed by the body," Hohenester explains the special feature of the pastilles.
"The innovation at tigosol is also the addition of the bacterial strain Bacillus subtilis with one billion spores per soft pastille. This combination, vitamin D, green tea and the power bacterium Bacillus subtillis, is unique in the market."
The new tigosol vitamin D complex was synergistically coordinated and developed to complement the tigovit green tea complex. Both premium preparations are intended as an optimal supplement for the modern woman in everyday life.
